Compare Heron Therapeutics Inc (HRTX) vs STMicroelectronics NV (STM) Price & Performance

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

STM trades at $61.57, down 0.79% with a bearish technical signal. The stock shows mixed fundamentals with a high P/E of 387.88 but strong analyst support (51.72% buy rating). Recent earnings have been inconsistent with two misses in the last three quarters, though Q3 2025 beat expectations. The company maintains solid cash flow generation of $555M in 2025 and is expanding AI partnerships with AWS and NVIDIA to drive future growth.

STM presents a cautious opportunity with 15% upside to the $72.33 consensus target, supported by AI expansion but tempered by declining revenue and thin 1.19% net margins. Key risks include execution on AI initiatives and semiconductor market volatility. The current price near support at $60 offers potential entry but requires monitoring of Q2 earnings due soon.